Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Gamerschlag

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Scientific Reports|September 12, 2025
Sequential factor delivery enables efficient workflow for universal gene editing in clinical grade iPS cellsThomas Berger, Elitsa Borisova, Anna Gamerschlag, et al.
Cytotherapy|April 2, 2026
Validated GMP banking of a new set of genomically stable induced pluripotent stem cell lines using single-cell passagingBjörn Hiller, Francois Hafezi, Jens Lichte, et al.
Stem Cells Translational Medicine|July 23, 2024
GMP-compliant iPS cell lines show widespread plasticity in a new set of differentiation workflows for cell replacement and cancer immunotherapyDaniel Terheyden-Keighley, Melanie Hühne, Thomas Berger, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Scientific Reports|September 12, 2025
Sequential factor delivery enables efficient workflow for universal gene editing in clinical grade iPS cellsThomas Berger, Elitsa Borisova, Anna Gamerschlag, et al.
Cytotherapy|April 2, 2026
Validated GMP banking of a new set of genomically stable induced pluripotent stem cell lines using single-cell passagingBjörn Hiller, Francois Hafezi, Jens Lichte, et al.
Stem Cells Translational Medicine|July 23, 2024
GMP-compliant iPS cell lines show widespread plasticity in a new set of differentiation workflows for cell replacement and cancer immunotherapyDaniel Terheyden-Keighley, Melanie Hühne, Thomas Berger, et al.
Pageof 1